BioSpace News Archive

Sonendo, Inc. today announced that it will report financial results for the first quarter 2023 after the market close on Tuesday, May 9th , 2023.

Palatin Technologies, Inc. today announced The International Journal of Molecular Sciences published a manuscript, “Stimulating the Melanocortin System in Uveitis and Diabetes Preserves the Structure and Anti-Inflammatory Activity of the Retina” by Tat Fong Ng and Andrew W. Taylor from Department of Ophthalmology, Boston University Chobanian and Avedisian School of Medicine, in Boston, Massachusetts.

Cultivarium and ATCC have entered a multi-phase research collaboration to expand the use of non-model microorganisms.

ProQR Therapeutics NV. announced the Annual General Meeting of Shareholders will take place on Wednesday, May 17, 2023 at 16:00 CET at the offices of Allen & Overy LLP, in Amsterdam, the Netherlands.

Nuvectis Pharma, Inc. today provided highlights from the poster presentation of NXP800 that took place yesterday at the American Association for Cancer Research (“AACR”) Annual Meeting 2023 in Orlando, FL (to view the poster, titled Inhibition of HSF1 Demonstrates Therapeutic Efficacy in Preclinical PDX Models of Human Cholangiocarcinoma.

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that it will report operating and financial results for the first quarter ended March 31, 2023 after the market close on Tuesday, May 2, 2023.

Science 37 Holdings, Inc., the industry-leading Metasite™, announced the appointment of Irena Lambridis as its Global Head of Quality Assurance & Compliance.

Daré Bioscience, Inc. today announced that Climacteric , the official journal of the International Menopause Society, published safety and acceptability results from a Phase 1 clinical trial of DARE-HRT1.

Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an overview of the Company’s MasterKey programs, including BDTX-1535 and BDTX-4933, at the Stifel 2023 Targeted Oncology Days on Tuesday, April 25, 2023.

CIBMTR® announced that the results of a multi-center observational study, around the impact of cryopreserved hematopoietic stem cell grafts on patient survival rates were published in Blood Advances, a peer-reviewed open access medical journal published by the American Society of Hematology.